Developmental toxicity of inorganic arsenic in whole embryo culture: Oxidation state, dose, time, and gestational age dependence

Toxicology and Applied Pharmacology

Volumn 138, Issue 2, 1996, Pages 298-307

  Tabacova, S ^a,c   Hunter III, E S ^a,d   Gladen, B C ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENATE SODIUM; ARSENIC; ARSENITE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DOSE TIME EFFECT RELATION; EMBRYO; EMBRYO CULTURE; EMBRYO GROWTH; EMBRYOTOXICITY; GESTATIONAL AGE; MOUSE; NONHUMAN; OXIDATION; TERATOGENICITY;

ANIMALIA;

EID: 0030175416     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0128     Document Type: Article

References (18)

1. Carpenter, S. J., and Ferm, V. H. (1977). Early stages in the development of exencephaly in arsenic-treated hamster embryos. Teratology 15, 23A-24A. [Abstract]
2. Chaineau, E., Binet, S., Pol, D., Chatellier, G., and Meinninger, V. (1990). Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. Teratology 41, 105-112.
3. Eastman, N. J. (1931). The arsenic content of the human placenta following arsphenamine therapy. Am. J. Obstet. Gynecol. 21, 60. (as cited by Ferm, V. H. (1977). Arsenic as a teratogenic agent. Environ. Health Perspect. 19, 215-217.)
4. Eastman, N. J. (1931). The arsenic content of the human placenta following arsphenamine therapy. Am. J. Obstet. Gynecol. 21, 60. (as cited by Ferm, V. H. (1977). Arsenic as a teratogenic agent. Environ. Health Perspect. 19, 215-217.)
5. Ferm, V. H. (1977). Arsenic as a teratogenic agent. Environ. Health Perspect. 19, 215-217.
6. Fisher, D. L. (1982). Cultured rat embryos accumulation of DNA, RNA, and protein following maternal administration of sodium arsenate. Environ. Res. 28, 1 -9.
7. Hanlon, D. P., and Ferm, V. H. (1984). The concentration and chemical status of arsenic in the early placentas of arsenate-treated hamsters. Environ. Res. 42, 546-552.
8. Harrison, W. P., and Hood, R. D. (1981). Prenatal effects following exposure of hamsters to sodium arsenite by oral or intraperitoneal routes. Teratology 23, 40A. [Abstract].
9. Hood, R. D. (1972). Effects of sodium arsenite on fetal development. Bull. Environ. Contam. Toxicol. 7, 216-222.
10. Hood, R. D., and Bishop, S. L. (1972). Teratogenic effects of sodium arsenate in mice. Arch. Environ. Health 24, 62-65.
11. Hood, R. D., Vedol-Macrander, G. C., Zaworotho, M. J., Tatum, F. M., and Meeks, R. G. (1987). Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology 35, 19-25.
12. Hood, R. D., Vedel, G. C., Zaworotho, M. J., and Tatum, F. M. (1988). Uptake, distribution and metabolism of trivalent arsenic in the pregnant mouse. J. Toxicol. Environ. Health 25, 423-434.
13. Lindgren, A., Danielsson, B. R. G., Denker, L., and Vahter, M. (1984). Embryotoxicity of arsenite and arsenate: Distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta. Pharmacol. Toxicol. 54, 311-320.
14. New, D. A. T. (1978). Whole embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. 53, 81-122.
15. Sadler, T. W. (1979). Culture of early somite embryos during organogenesis. J. Embryol. Exp. Morphol. 49, 17-25.
16. Snyder, F. F., and Speert, H. (1938). The placental transmission of neoarsphenamine in relation to the stage of pregnancy. Am. J. Obstet. Gynecol. 36, 579-586.
17. WHO (1981). WHO Environmental Health Criteria 18: Arsenic, pp. 43-49; 88-122. IPCS International Programme on Chemical Safety, WHO, Geneva.
18. Willhite, C. C., and Ferm, V. H. (1984). Prenatal and developmental toxicity of arsenicals. Adv. Exp. Med. Biol. 177, 205-228.